JAYAKUMAR PATIL: Open Payments
NPI 1144339417 · BEDFORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 29 payments from 9 companies in 2025. Trend: 2023 $999 · 2024 $798 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $350 |
| ABBVIE INC. | 7 | $201 |
| Vanda Pharmaceuticals Inc. | 3 | $161 |
| Lundbeck LLC | 7 | $151 |
| Axsome Therapeutics, Inc. | 2 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Biogen, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $16 |
Products named: SPRAVATO, REXULTI, VRAYLAR, FANAPT, Auvelity, CAPLYTA, ZURZUVAE, ARISTADA.
Industry payments across NH — which companies pay providers there.
